INDIA – Qure.ai, a Mumbai, India-, NYC- and Birmingham, UK-based health tech company using Artificial Intelligence (AI) for medical imaging diagnostics, secured $40m in funding.
The round was led by Novo Holdings and HealthQuad, with participation from existing investor MassMutual Ventures. Existing investors included Fractal analytics and Sequoia Capital.The company will use the new funding to extend and strengthen its global reach, especially in the US and Europe, and intensify product development for critical care and community diagnostics. Led by Prashant Warier, CEO and Founder, Qure.ai is an Artificial Intelligence (AI) solution provider that is enhancing imaging accuracy and improving health outcomes with the assistance of machine-supported tools. The company leverages deep learning technology to provide automated interpretation of radiology examinations like X-rays, CTs, Ultrasounds and MRI scans for time and resource-strapped medical imaging professionals—enabling fast diagnosis and speed to treatment.Qure’s AI solutions are FDA-approved, CE-certified, and evaluated by the World Health Organization.29/03/2022
